These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 26415927)

  • 1. RDTs as a source of DNA to study Plasmodium falciparum drug resistance in isolates from Senegal and the Comoros Islands.
    Papa Mze N; Ndiaye YD; Diedhiou CK; Rahamatou S; Dieye B; Daniels RF; Hamilton EJ; Diallo M; Bei AK; Wirth DF; Mboup S; Volkman SK; Ahouidi AD; Ndiaye D
    Malar J; 2015 Sep; 14():373. PubMed ID: 26415927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High prevalence of sulphadoxine-pyrimethamine resistance-associated mutations in Plasmodium falciparum field isolates from pregnant women in Brazzaville, Republic of Congo.
    Koukouikila-Koussounda F; Bakoua D; Fesser A; Nkombo M; Vouvoungui C; Ntoumi F
    Infect Genet Evol; 2015 Jul; 33():32-6. PubMed ID: 25934142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic polymorphisms associated with sulphadoxine-pyrimethamine drug resistance among Plasmodium falciparum field isolates in malaria endemic areas of Assam.
    Sharma J; Dutta P; Khan SA; Soni M; Dey D; Mahanta J
    J Postgrad Med; 2015; 61(1):9-14. PubMed ID: 25511211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frequencies distribution of dihydrofolate reductase and dihydropteroate synthetase mutant alleles associated with sulfadoxine-pyrimethamine resistance in Plasmodium falciparum population from Hadhramout Governorate, Yemen.
    Bamaga OA; Mahdy MA; Lim YA
    Malar J; 2015 Dec; 14():516. PubMed ID: 26693691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of sulfadoxine-pyrimethamine resistance-associated mutations in dhfr and dhps genes of Plasmodium falciparum three years after SP withdrawal in Bahir Dar, Northwest Ethiopia.
    Hailemeskel E; Kassa M; Taddesse G; Mohammed H; Woyessa A; Tasew G; Sleshi M; Kebede A; Petros B
    Acta Trop; 2013 Dec; 128(3):636-41. PubMed ID: 24055717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ordered accumulation of mutations conferring resistance to sulfadoxine-pyrimethamine in the Plasmodium falciparum parasite.
    Mita T; Ohashi J; Venkatesan M; Marma AS; Nakamura M; Plowe CV; Tanabe K
    J Infect Dis; 2014 Jan; 209(1):130-9. PubMed ID: 23922363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High prevalence of dhfr and dhps molecular markers in Plasmodium falciparum in pregnant women of Nchelenge district, Northern Zambia.
    Siame MN; Mharakurwa S; Chipeta J; Thuma P; Michelo C
    Malar J; 2015 May; 14():190. PubMed ID: 25943379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High prevalence of sulfadoxine/pyrimethamine resistance alleles in Plasmodium falciparum parasites from Bangladesh.
    Marma AS; Mita T; Eto H; Tsukahara T; Sarker S; Endo H
    Parasitol Int; 2010 Jun; 59(2):178-82. PubMed ID: 20097306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High resolution melting: a useful field-deployable method to measure dhfr and dhps drug resistance in both highly and lowly endemic Plasmodium populations.
    Ndiaye YD; Diédhiou CK; Bei AK; Dieye B; Mbaye A; Mze NP; Daniels RF; Ndiaye IM; Déme AB; Gaye A; Sy M; Ndiaye T; Badiane AS; Ndiaye M; Premji Z; Wirth DF; Mboup S; Krogstad D; Volkman SK; Ahouidi AD; Ndiaye D
    Malar J; 2017 Apr; 16(1):153. PubMed ID: 28420422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA recovery from archived RDTs for genetic characterization of Plasmodium falciparum in a routine setting in Lambaréné, Gabon.
    Nguyen TT; Nzigou Mombo B; Lalremruata A; Koehne E; Zoleko Manego R; Dimessa Mbadinga LB; Adegnika AA; Agnandji ST; Lell B; Kremsner PG; Velavan TP; Ramharter M; Mordmüller B; Mombo-Ngoma G
    Malar J; 2019 Oct; 18(1):336. PubMed ID: 31578142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Source of drug resistant Plasmodium falciparum in a potential malaria elimination site in Saudi Arabia.
    Al-Farsi HM; Al-Hashami ZS; Bin Dajem SM; Al-Sheikh AA; Al-Qahtani A; Beja-Pereira A; Idris MA; Babiker HA
    Infect Genet Evol; 2012 Aug; 12(6):1253-9. PubMed ID: 22709478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DHFR and DHPS genotypes of Plasmodium falciparum isolates from Gabon correlate with in vitro activity of pyrimethamine and cycloguanil, but not with sulfadoxine-pyrimethamine treatment efficacy.
    Aubouy A; Jafari S; Huart V; Migot-Nabias F; Mayombo J; Durand R; Bakary M; Le Bras J; Deloron P
    J Antimicrob Chemother; 2003 Jul; 52(1):43-9. PubMed ID: 12805261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High prevalence of sulfadoxine/pyrimethamine-resistant alleles of Plasmodium falciparum isolates in pregnant women at the time of introduction of intermittent preventive treatment with sulfadoxine/pyrimethamine in Gabon.
    Bouyou-Akotet MK; Mawili-Mboumba DP; Tchantchou Tde D; Kombila M
    J Antimicrob Chemother; 2010 Mar; 65(3):438-41. PubMed ID: 20053688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug resistance to sulphadoxine-pyrimethamine in Plasmodium falciparum malaria in Mlimba, Tanzania.
    Mbugi EV; Mutayoba BM; Malisa AL; Balthazary ST; Nyambo TB; Mshinda H
    Malar J; 2006 Oct; 5():94. PubMed ID: 17076899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The implication of dihydrofolate reductase and dihydropteroate synthetase gene mutations in modification of Plasmodium falciparum characteristics.
    A-Elbasit IE; Alifrangis M; Khalil IF; Bygbjerg IC; Masuadi EM; Elbashir MI; Giha HA
    Malar J; 2007 Aug; 6():108. PubMed ID: 17686173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Markers of sulfadoxine-pyrimethamine resistance in Eastern Democratic Republic of Congo; implications for malaria chemoprevention.
    van Lenthe M; van der Meulen R; Lassovski M; Ouabo A; Bakula E; Badio C; Cibenda D; Okell L; Piriou E; Grignard L; Lanke K; Rao B; Bousema T; Roper C
    Malar J; 2019 Dec; 18(1):430. PubMed ID: 31852480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasmodium falciparum resistant to chloroquine and to pyrimethamine in Comoros.
    Randrianarivelojosia M; Raherinjafy RH; Migliani R; Mercereau-Puijalon O; Ariey F; Bedja SA
    Parasite; 2004 Dec; 11(4):419-23. PubMed ID: 15638145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urban malaria in Dakar, Senegal: chemosusceptibility and genetic diversity of Plasmodium falciparum isolates.
    Henry M; Diallo I; Bordes J; Ka S; Pradines B; Diatta B; M'Baye PS; Sane M; Thiam M; Gueye PM; Wade B; Touze JE; Debonne JM; Rogier C; Fusai T
    Am J Trop Med Hyg; 2006 Jul; 75(1):146-51. PubMed ID: 16837722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinct haplotypes of dhfr and dhps among Plasmodium falciparum isolates in an area of high level of sulfadoxine-pyrimethamine (SP) resistance in eastern Sudan.
    Al-Saai S; Kheir A; Abdel-Muhsin AM; Al-Ghazali A; Nwakanma D; Swedberg G; Babiker HA
    Infect Genet Evol; 2009 Sep; 9(5):778-83. PubMed ID: 19379843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A molecular epidemiologic study of point mutations for pyrimethamine-sulfadoxine resistance of Plasmodium falciparum isolates from Lao PDR.
    Toma H; Imada Y; Vannachone B; Miyagi M; Kobayashi J; Uechi G; Pethuvang R; Manivong K; Phompida S; Sato Y
    Southeast Asian J Trop Med Public Health; 2005 May; 36(3):602-4. PubMed ID: 16124424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.